About ZaBeCor
ZaBeCor is a clinical stage biotechnology company focused on the development of siRNA, antisense and other molecular technologies for the treatment of asthma, allergy and other inflammatory and infectious diseases.
ZaBeCor Research
ZaBeCor is working to research and develop innovative treatments that could reach millions of patients. From asthma and allergy to other inflammatory and infectious diseases, our research is helping to shape The Future of siRNA™.
ZaBeCor Licensing
ZaBeCor’s intellectual property represents some of the industry's leading technologies that could result in major treatments. We strongly believe that partnerships and strategic alliances can help achieve significant impact through collaborative drug discovery and development.